HIV
Coverage of HIV in the Nexus archive.
- ‘We are living in reverse’: Fragile HIV funding puts another strain on Kansas City’s safety net
Despite significant progress and successful changes in HIV care over the decades, public health experts warn that funding cuts pose a major threat to current efforts. The Trump administration's proposed 2027 budget requests elimination of $1.6 billion in HIV-related spending, threatening parts of the Ryan White HIV/AIDS Program. Activists are concerned that these potential cuts will reverse years of progress and make essential resources unavailable.
- Disgraced Florida pastor allegedly had sex with young teen 3 times — and failed to mention he was HIV positive
Timothy Chaneyfield, a Florida pastor, is accused of sexually abusing a 14-year-old at his Eagle Creek home on three occasions and not disclosing his HIV status. Polk County Sheriff Grady Judd announced the allegations at a press conference.
- Florida pastor accused of having sex with 14-year-old boy, not revealing HIV diagnosis
A pastor from St James Freewill United American Baptist Church in Winter Haven, Fla., is accused of having sex with a 14-year-old boy and failing to disclose an HIV diagnosis. The incident involves allegations of inappropriate conduct and health-related non-disclosure.
- Florida pastor accused of having sex with teen, not disclosing HIV status
A Florida pastor is accused of having sex with a 14-year-old boy and failing to disclose his HIV status. The boy reportedly met the pastor through a mobile dating app and continued communication via Instagram.
- Russia Says Its HIV Rates Are Falling. Experts Aren’t So Sure.
Russia claims its HIV rates are declining, but experts argue official statistics mask a worsening public health crisis exacerbated by the Ukraine war.
- ‘Pedophile preacher’: Pastor accused of sexually abusing 14-year-old, exposing teen to HIV
A Florida pastor, Timothy Chaneyfield, is accused of sexually abusing a 14-year-old boy and exposing him to HIV. He was arrested and charged with multiple offenses, including lewd battery of a minor, traveling to meet a minor, and failing to disclose his HIV status during sexual encounters.
- ‘Pedophile preacher’: Pastor accused of sexually abusing 14-year-old, exposing teen to HIV
A Florida pastor, Timothy Chaneyfield, is accused of sexually abusing a 14-year-old boy and exposing him to HIV. He was arrested after a cyber tip from Instagram led investigators to confirm the abuse and his HIV-positive status, which he allegedly did not disclose to the victim or another adult partner.
- ‘Pedophile preacher’: Pastor accused of sexually abusing 14-year-old, exposing teen to HIV
A Florida pastor, Timothy Chaneyfield, is accused of sexually abusing a 14-year-old boy and exposing him to HIV. He was arrested after a cyber tip led investigators to discover he met the minor via a dating app and Instagram, picked him up multiple times, and admitted to sexual activity. Chaneyfield, who is HIV positive and taking medication, did not disclose his status to the victim or a previous sexual partner.
- STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
The California Supreme Court ruled in favor of Gilead Sciences in a case where patients alleged the company was negligent for delaying the development of a safer HIV drug. The court overturned a prior decision holding Gilead liable, alleviating concerns in the pharmaceutical industry about legal risks influencing drug development.
- Malawi: Community-Led HIV Care Gives Malawi a Blueprint for Ending Mother-to-Child Transmission
Malawi is making progress toward eliminating mother-to-child HIV transmission through a community-based care and treatment program. The program shows a very low HIV positivity rate among HIV-exposed infants across nine districts.
- South Africa: Fake Hit, HIV Case and Corruption Battles Rock Gauteng Courts
Brown Mogotsi returns to court after failing to win bail, Vusimuzi 'Cat' Matlala's trial within a trial continues, and a Pretoria man accused of deliberately infecting his former girlfriend with HIV faces court proceedings. The Democratic Alliance calls for the anti-corruption unit to be scrapped.
- Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year
A year-long extension of the PURPOSE 1 and PURPOSE 2 trials found that twice-yearly injectable lenacapavir (Yeztugo) for HIV PrEP resulted in only one new HIV infection. The drug demonstrated high effectiveness in preventing HIV over the study period.
- New HIV infections in Canada are rising. Advocates say years of progress is at risk
Data from the Public Health Agency of Canada showed a 22.8% increase in HIV infections, with advocates warning that progress toward eliminating HIV as a public health threat is at risk of slowing and infections could resurge.
- Brazil’s HIV advocates say they predicted USAID funding cuts: ‘We would see the trends’
Brazilian HIV advocates at the Aids 2026 conference predicted a reduction in USAID funding for HIV, emphasizing the need for health systems to be independent from foreign aid. They stated that the dissolution of USAID was anticipated, with Juliana Cesar from the Brazilian HIV NGO Gestos highlighting this during a conference session.
- Enugu reaffirms commitment to HIV response through partnerships
Enugu reaffirms its commitment to responding to HIV through partnerships. The Commissioner for Health, George Ugwu, met with the Network of People Living with HIV and AIDS in Nigeria, Enugu Chapter.
- Uganda: HIV Injection Is Not a Vaccine, Experts Warn
Experts in Uganda have warned that the HIV prevention injection Lenacapavir is not a vaccine and advised users to combine it with other prevention methods.
- Africa: Climate Change is Now an Immediate Threat to HIV Control
The article highlights that in Africa, people most affected by HIV are also the most vulnerable to climate change, indicating an immediate threat to HIV control efforts.
- Two Drugs Matched Three for Untreated HIV
A two-drug regimen was found to be noninferior to a three-drug regimen as initial antiretroviral therapy (ART) for untreated HIV in adults, with 89% achieving an HIV-1 RNA level of less than 50 copies/mL at week 48 in a phase IIIb trial.
- Africa: HIV Science Races Ahead As Funding Crisis Threatens to Widen Access Gap
Scientific innovation and international financing have transformed HIV into a manageable condition for millions, but a funding crisis threatens to widen access gaps. The article highlights the progress made over two decades in Africa.
- Advocates puzzled after HIV is left off of Georgia’s ‘medically frail’ list for Medicaid work rules
Georgia officials excluded HIV from a list of 'medically frail' conditions that would exempt low-income residents from Medicaid work requirements. Advocates argue this omission could worsen health outcomes and increase costs for the state. The proposed rule, aligning with federal Medicaid changes, is under review by the Georgia Department of Community Health ahead of an August 13 board meeting.
- Africa: South Africa's Next HIV Battle Isn't About Science, It's About Access
South Africa, long at the epicenter of the global HIV epidemic, is now testing a twice-yearly injection that offers nearly complete protection against HIV. This advancement is seen as a major breakthrough in HIV prevention, shifting focus from scientific innovation to ensuring access.
- Uganda: U=U Gave Me My Future Back - Ugandan Activist William Matovu on Replacing HIV Fear With Hope
William Matovu, a Ugandan activist, shares how the U=U campaign helped him overcome HIV-related fear and reclaim hope. The article highlights his personal journey with HIV in Uganda.
- Ask Dr. Nandi: What new guidelines could mean for how young adults manage 'bad' cholesterol
New guidelines expand statin eligibility to adults as young as 30, lowering cardiovascular risk thresholds and considering 30-year risk. A study estimates 21.5 million more Americans may qualify for statin therapy to prevent heart attacks or strokes, based on health data from 4,300 adults aged 30-79. The guidelines emphasize consulting doctors to assess individual risk factors like high LDL, diabetes, or family history.
- STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
GSK CEO Luke Miels announced a three-year cost-cutting plan targeting 1.9 billion pounds in annual savings by 2029, with funds reinvested into late-stage drug trials. The company aims to increase Phase 3 trials from 10 to 20 this year, focusing on areas like oncology, liver disease, vaccines, and HIV.
- The Unmaking of Anthony Fauci
Anthony Fauci is testifying before Congress under a subpoena, marking a shift from his decades-long career as a respected scientist and public health leader. Known for his work on AIDS research, HIV treatments, and the PEPFAR program, Fauci now faces scrutiny amid threats and political polarization, contrasting with his past reputation as a nonpartisan figure.
- Africa: Rethink. Rebuild. Rise. - AIDS 2026 Charts the Next Phase of the HIV Response
The global fight against HIV now has powerful scientific tools but faces political uncertainty. The article highlights the need for a new phase of response as outlined in the 'AIDS 2026' initiative.
- Advocates puzzled after HIV is left off of Georgia’s ‘medically frail’ list for Medicaid work rules
Georgia officials excluded HIV from a list of conditions exempting low-income residents from Medicaid work requirements, raising concerns from health advocates. The state's proposed policy aligns with federal Medicaid changes requiring work or community service for coverage, but advocates argue excluding HIV could worsen health outcomes and increase costs. A decision on the policy is pending a state board meeting.
- South Africa: Study Finds HIV-Specific Immune Activity in Central Nervous System Despite Viral Suppression in Blood
A 16-year study in South Africa found HIV-specific immune activity in the central nervous system of adolescents despite viral suppression in the blood. The study is part of one of the world's longest-running HIV research efforts.
- Africa: 'Science is Not the Problem' - UNAIDS Says Political Choices Now Threaten HIV Response
UNAIDS states political choices now threaten the HIV response, as international funding declines and prevention programs are scaled back in countries hardest-hit by HIV. Health leaders warn decades of progress are at risk.
- STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
Global funding to combat HIV fell by 18% to $7.3 billion in 2025, raising fears of a resurgence. Prevention programs, especially in sub-Saharan Africa where donor reliance reached 83%, are critically impacted. The decline is attributed to reduced government funding, high debt burdens in affected countries, and setbacks in human rights and gender equality.
- Africa: What the AIDS Funding Withdrawal Revealed About African Health Law
The United States is scaling back support for Africa's HIV response, leading to a funding crisis and revealing constitutional and ethical challenges. Legal scholar Mnotho Ngcobo highlights these issues as Africa confronts the withdrawal of donor funding.
- Burundi: 'A Doctor Told Me to Buy My Coffin' - How Eric Turned an HIV Diagnosis Into Activism
Eric, a 26-year-old in Burundi, was told by a doctor to plan for his funeral and abandon the idea of having children after being diagnosed with HIV. Instead of giving up, he transformed his experience into activism.
- Africa: Twice-Yearly Lenacapavir Continues to Show Strong HIV Prevention Results
Twice-yearly injectable lenacapavir has continued to demonstrate exceptional protection against HIV infection. The drug shows strong HIV prevention results as reported by allAfrica.
- South Africa: Positive Interim Findings On New Once-Weekly HIV Treatment Pill
A new antiretroviral combination pill taken once a week shows effectiveness comparable to daily HIV treatments, according to interim study findings. The results will be presented at the AIDS 2026 conference in Rio de Janeiro, Brazil.
- Kano intensifies campaign to eliminate mother-to-child transmission of HIV, Hepatitis B, Syphilis
Kano state is intensifying efforts to eliminate mother-to-child transmission of HIV, Hepatitis B, and Syphilis. Mr. Yusuf highlighted that these infections are largely preventable, with syphilis being curable when detected and treated early.
- How to Cope With Scanxiety: 10 Expert Tips While Waiting for Test Results
The article discusses scanxiety, the anxiety experienced while waiting for medical test results, and its impact on physical health. It highlights causes like uncertainty from diagnostic procedures and provides coping strategies. Examples include waiting for mammograms, blood tests for HIV or Lyme disease, and delays in specialist appointments.
- US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
A new report claims the Trump administration's disruptions to a global AIDS relief program have caused clinics to close, staff layoffs, and reduced services, hindering HIV prevention and treatment in dozens of countries.
- South Africa: What The Polygamist Gets Wrong About HIV and What Would Save Lives in Real Life
The article discusses how HIV stigma, rather than the virus itself, remains a deadly force in South Africa, as depicted in Netflix's 'The Polygamist' where a character dies of an AIDS-related illness. It highlights the importance of addressing shame and silence at an HIV conference in Rio.
- Healthcare body finds unsafe needle disposal at Valika Hospital
The Sindh Healthcare Commission found unsafe needle disposal practices at Valika Hospital in Karachi, including manual needle removal and improper medical waste segregation, following an HIV outbreak that infected 78 children. The hospital lacked formal infection prevention training, written guidelines, and proper waste management protocols, raising serious safety concerns.
- How HIV Started a Century Before Anyone Noticed
The article explains that the 'Patient Zero' narrative for bringing AIDS to America was incorrect, revealing through genetic research that HIV originated from chimpanzees in Central Africa and evolved into a global pandemic. Scientific analysis debunked the myth, tracing the virus's true history.